Update of clinical trials with edrecolomab: a monoclonal antibody therapy for colorectal cancer (Q43556115)

24 November 2017

Update of clinical trials with edrecolomab: a monoclonal antibody therapy for colorectal cancer (English)

1 reference

24 November 2017

1 reference

Haller DG

1

1 reference

24 November 2017

1 February 2001

1 reference

24 November 2017

1 reference

24 November 2017

28

1 reference

24 November 2017

1 Suppl 1

1 reference

24 November 2017

25-30

1 reference

The biology of the 17-1A antigen (Ep-CAM)

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990248-9

7 January 2021

The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990248-9

7 January 2021

Tumor-associated antigen expression of primary and metastatic colon carcinomas detected by monoclonal antibody 17-1A

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990248-9

7 January 2021

Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A).

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990248-9

7 January 2021

Binding of murine immunoglobulin to human tissues after immunotherapy with anticolorectal carcinoma monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990248-9

7 January 2021

Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990248-9

7 January 2021

Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990248-9

7 January 2021

Induction of anti-idiotypic (ab2) and anti-anti-idiotypic (ab3) antibodies in patients treated with the mouse monoclonal antibody 17-1A (ab1). Relation to the clinical outcome--an important antitumoral effector function?

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990248-9

7 January 2021

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990248-9

7 January 2021

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990248-9

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990248-9

7 January 2021

10.1016/S0093-7754(01)90248-9

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

11273586